Filing Details
- Accession Number:
- 0001209191-10-038435
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-07-14 13:00:00
- Reporting Period:
- 2010-07-12
- Filing Date:
- 2010-07-14
- Accepted Time:
- 2010-07-14 16:16:43
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1009356 | Salix Pharmaceuticals Ltd | SLXP | Pharmaceutical Preparations (2834) | 943267443 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1053880 | F John Chappell | 1700 Perimeter Park Drive Morrisville NC 27560 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2010-07-12 | 300 | $39.98 | 493,820 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-07-12 | 20,062 | $40.56 | 473,758 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-07-12 | 4,638 | $41.08 | 469,120 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 250,000 | Indirect | By GRAT |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Option to Buy Common Stock | $17.63 | 2015-06-09 | 15,000 | 15,000 | Direct | |
| Common Stock | Option to Buy Common Stock | $18.87 | 2014-06-17 | 22,500 | 22,500 | Direct | |
| Common Stock | Option to Buy Common Stock | $7.60 | 2013-07-24 | 15,000 | 15,000 | Direct | |
| Common Stock | Option to Buy Common Stock | $4.07 | 2012-07-02 | 15,000 | 15,000 | Direct | |
| Common Stock | Option to Buy Common Stock | $4.92 | 2001-01-01 | 2010-12-31 | 22,500 | 22,500 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2015-06-09 | 15,000 | 15,000 | Direct |
| 2014-06-17 | 22,500 | 22,500 | Direct |
| 2013-07-24 | 15,000 | 15,000 | Direct |
| 2012-07-02 | 15,000 | 15,000 | Direct |
| 2010-12-31 | 22,500 | 22,500 | Direct |
Footnotes
- The shares were sold pursuant to a Rule 10b5-1 trading plan.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.01 and $40.99, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.00 and $41.16, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.
- These shares were previously reported as directly benefically owned but were contributed to a grantor retained annuity trust on October 30, 2007.
- Options are 100% vested.
Billionaire Hedge Funds
